IMRN logo

IMRN
IMMURON Ltd/S ADR

5,494
Mkt Cap
$8.17M
Volume
11,203.00
52W High
$2.39
52W Low
$0.6765
PE Ratio
-2.08
IMRN Fundamentals
Price
$1.00
Prev Close
$0.98
Open
$0.982
50D MA
$0.8406
Beta
0.86
Avg. Volume
35,388.10
EPS (Annual)
-$0.5852
P/B
0.94
$6.20
Loading...
Loading...

About

Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. It operates through the Hyper-immune Products and Research and Development (R&D) segments. The Hyper-immune Products segment includes income and expenses directly attributable to Travelan and Protectyn activities. The Research and Development segment refers to the group’s R&D projects performed in Australia and United States. The company was founded on January 13, 1994, and is headquartered in Blackburn, Australia.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Immuron Limited - ADR?
What is the 52-week high for Immuron Limited - ADR?
What is the 52-week low for Immuron Limited - ADR?
What is Immuron Limited - ADR stock price today?
What was Immuron Limited - ADR stock price yesterday?
What is the PE ratio of Immuron Limited - ADR?
What is the Price-to-Book ratio of Immuron Limited - ADR?
What is the 50-day moving average of Immuron Limited - ADR?

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available
Top Discussions

Advertisement|Remove ads.